Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).
Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice.
TOX is expressed by exhausted and polyfunctional human effector memory CD8 + T cells
Correction to: Novel Approaches Towards a Functional Cure of HIV/AIDS.
Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya.
Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study.
In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.